Hanseatic Management Services Inc Fate Therapeutics Inc Transaction History

Hanseatic Management Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$67.25 - $92.52 $4,371 - $6,013	-65 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$38.09 - $100.95 $3,580 - $9,489	-94 Reduced 59.12%	65 $6,000
Q3 2020 Oct 29, 2020	BUY	$30.41 - $40.5 $1,672 - $2,227	55 Added 52.88%	159 $6,000
Q1 2020 Apr 22, 2020	BUY	$17.28 - $31.88 $1,797 - $3,315	104 New	104 $2,000

167

101M

41.3K

15.9K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $88.3M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.